GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Decreased by PDT Partners LLC

PDT Partners LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 25.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 43,364 shares of the company's stock after selling 14,501 shares during the quarter. PDT Partners LLC's holdings in GE HealthCare Technologies were worth $4,070,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. B. Riley Wealth Advisors Inc. boosted its holdings in GE HealthCare Technologies by 17.0% in the first quarter. B. Riley Wealth Advisors Inc. now owns 7,404 shares of the company's stock worth $673,000 after purchasing an additional 1,074 shares during the period. Swedbank AB acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $6,138,000. Atria Investments Inc bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at about $1,300,000. Burney Co. raised its stake in GE HealthCare Technologies by 6.3% during the first quarter. Burney Co. now owns 11,102 shares of the company's stock worth $1,009,000 after acquiring an additional 657 shares during the period. Finally, Cetera Investment Advisers lifted its holdings in GE HealthCare Technologies by 569.9% in the first quarter. Cetera Investment Advisers now owns 68,474 shares of the company's stock worth $6,225,000 after acquiring an additional 58,252 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Insider Activity

In other news, CEO Roland Rott sold 3,577 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.27% of the company's stock.

Analysts Set New Price Targets

GEHC has been the subject of several recent research reports. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a "neutral" rating and a $90.00 target price for the company. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. BTIG Research raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. UBS Group downgraded shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and reduced their price target for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Finally, Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a report on Monday, September 30th. One analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $94.36.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC traded up $0.22 during mid-day trading on Friday, reaching $83.22. 1,277,723 shares of the company traded hands, compared to its average volume of 3,071,344. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55. The firm has a market cap of $38.02 billion, a PE ratio of 22.86, a price-to-earnings-growth ratio of 2.97 and a beta of 1.24. The stock has a fifty day simple moving average of $87.78 and a 200-day simple moving average of $83.62. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion for the quarter, compared to analysts' expectations of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm's revenue for the quarter was up .9% on a year-over-year basis. During the same period last year, the firm earned $0.99 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies's dividend payout ratio is presently 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.